Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells

BIOMEDICINE & PHARMACOTHERAPY · Published 2026-07-30 · DOI 10.1016/j.biopha.2026.119786

Free full text

Authors (10)

Phakorn Papan, Jiraporn Kantapan, Sucheewin Krobthong, Yodying Yingchutrakul, Sujitra Funsueb, Sila Kittiwachana, Hien Van doan, Puttinan Meepowpan, Nathupakorn Dechsupa, Padchanee Sangthong

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Papan, P., Kantapan, J., Krobthong, S., et al. (2026). Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells. BIOMEDICINE & PHARMACOTHERAPY. https://doi.org/10.1016/j.biopha.2026.119786

Related articles

• 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Fluorinated isoindolinone–amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal